Neoplasia/BPH

	Face and content validation of laser enucleation of prostate simulation model: an EAU European School of Urology (ESU) Lower Urinary Tract Endoscopy Working Group study. World J Urol Sener TE, de Oliveira TR, Demirkiran ED, Perri D, Pereira S, Caballero JP, Osorio L, Kartalas IG, Goossens M, Schoensee B, Dragos L, Veneziano D, Biyani CS, Somani B, Liatsikos E. PMID: 42090017 [PubMed - indexed for MEDLINE]
	Incidence and impact of pseudoprogression and mixed responses in metastatic renal cell carcinoma patients treated with ipilimumab/nivolumab: a retrospective analysis. Acta Oncol Caeyman A, Mammone G, Kinget L, Baldewijns M, De Wever L, Albersen M, Debruyne PR, Demeulenaere O, McTaggart ES, Saraswat S, Berghen C, De Meerleer G, Naulaerts S, Garg AD, Beuselinck B. PMID: 42089693 [PubMed - indexed for MEDLINE]
	Â¹â·â·lu-PSMA-617 radioligand therapy as an immune modulator in prostate cancer. Expert Rev Anticancer Ther Sciortino C, Nuzzo A, Stellato M, Claps M, Rametta A, Guadalupi V, Gusmaroli E, Rota S, Mascaro F, Giannatempo P, Zimatore M, Maccauro M, Huber V, Verzoni E, Procopio G. PMID: 42089687 [PubMed - as supplied by publisher]
	Multiparametric MRI in prostate cancer active surveillance: results from the Miami Active Surveillance Trial (MAST) trial. BJU Int Sharifi SHH, Williams A, Ryan JT, Ajami T, Nativ OF, Han S, Reis IM, Soodana-Prakash N, Khandekar A, Swain S, Kryvenko ON, Stoyanova R, Pollack A, Castillo PR, Nahar B, Ritch CR, Kava B, Gonzalgo ML, Parekh DJ, Punnen S. PMID: 42089595 [PubMed - as supplied by publisher]
	Multi-omics insights into tumor grade progression in clear cell renal cell carcinoma: from molecular mechanisms to precision therapeutics. Front Cell Dev Biol Jena RS, Mishra A. PMID: 42089114 [PubMed]
	Outcomes of pelvic radiotherapy with boost strategies in high nodal-risk prostate cancer: A phase 2 prospective trial. Clin Transl Radiat Oncol Thellenberg Karlsson C, Notstam K, Tavelin B, Lundqvist K, Fransson P, Söderkvist K. PMID: 42088776 [PubMed]
	Predicting Prostate Cancer Risk and Its Associated Factors Using Machine Learning Techniques: A Retrospective Study. Health Sci Rep Mohammadi S, Imani B, Saeedi S, Amirzargar MA. PMID: 42088668 [PubMed]
	The Brazilian Genome Map Oncology Subproject: a nationwide multicentre hospital-based whole-genome sequencing study of breast, prostate, and colorectal cancer. Lancet Reg Health Am Ferreira FO, Rossi BM, Palmero EI, Carvalho Barros LR, Domingos de Nicola P, Monteiro Dos Santos EM, Pereira de Souza J, Thiago de Souza-Santos P, Matta BP, da Silva Sabato C, Braz NC, Monteleone VF, Campacci N, Bastos GM, Guerra TS, Quirino CV, Pereira N, de Oliveira Costa M, Alves da Silva A, Serra AL, Lopes AJ, Alves Coelho BL, Mylla de Aguiar D, Chagas GL, Silva da Costa J, Lima JF, Jaqueline de Souza M, Oliveira SR, da Fonseca C, Cascapera F, Alencar de Moura FA, Perroni Dos Santos G, Guimaraes da Silva L, Campacci L, Sacilotto L, Soares Dos Santos S, Queiroz WDS, Goto GT, Badesso Fonseca TR, De Oliveira Mattoschoell VY, Rosa RO, Sandoval RL, Gambardella DD, Ciconelli RM, Beraldo da Costa Saad M, Guimaraes GC, Collaborative Working Group . PMID: 42088596 [PubMed]
	Real-world incidence of G3-G4 adverse events in patients with advanced renal cell carcinoma receiving immune-combinations (ARON-1). Front Immunol Beas-Lozano EL, Scagliarini S, Valdez-Sandoval PI, Esparza-Orozco MF, Bilen MA, Bamias A, Li H, Juan Fita MJ, Kopecky J, Manneh Kopp R, Ghosn M, Fay AP, Bhuva D, Kucharz J, Büttner T, Molina-Cerrillo J, Fiala O, Rizzo A, Maiorano BA, Soares A, Buti S, Marques Monteiro FS, Massari F, Santoni M, Bourlon MT. PMID: 42088516 [PubMed - indexed for MEDLINE]
	Advances in immunotherapy for renal cell carcinoma: a comprehensive review. Front Immunol Rajih E, Bakhsh A, Borhan WM, Alqahtani SAM. PMID: 42088496 [PubMed - indexed for MEDLINE]
	The efficacy of neoadjuvant chemohormonal therapy in combination with radical prostatectomy for locally advanced prostate cancer: a systematic review and meta-analysis. Front Oncol Luo H, Wang X, He C. PMID: 42088201 [PubMed]
	Clinical performance of the urine-based TERT promoter AbsoluteQ Digital PCR for non-invasive detection of bladder cancer. Mol Oncol Nykel A, Kubiak I, Rutkowska L, Kasprzyk , K, Bednarek M, Sobieraj D, Wilkosz J, Kania P, J, Ka, Gach A, Ka. PMID: 42087419 [PubMed - as supplied by publisher]
	Effectiveness and Safety of Interventions for Sarcopenia in Advanced Prostate Carcinoma: Systematic Review. J Cachexia Sarcopenia Muscle de Pablos-Rodríguez P, de Armas-Castellano A, Infante-Ventura D, Del Pino-Sedeño T, Domínguez AR, Pedrianes-Martín PB, Calbet JAL, de Pablos-Velasco P, Trujillo-Martín MM. PMID: 42087380 [PubMed - indexed for MEDLINE]
	Psychosocial factors and overall mortality after prostate cancer diagnosis among predominantly low-income Black and White adults. JNCI Cancer Spectr Demoulin D, Lipworth L, Aldrich MC, Russo LJ, Munro H, Kolitsopoulos F, Fisa R, Mwala K, Shrubsole MJ, Zheng W, Shu XO. PMID: 42087336 [PubMed - as supplied by publisher]
	The relationship between urethral catheterization before TUR-P and postoperative stricture. World J Urol Ataman M, Y, Yufka M, Gürtan E, Yuvanç E. PMID: 42086950 [PubMed - indexed for MEDLINE]
	A systematic review and meta-analysis of clinicopathologic factors associated with adverse oncologic outcomes in bladder cancer patients undergoing radical cystectomy: Evidence from multivariable survival prediction models. Urol Oncol Artiles Medina A, Subiela JD, Muriel García A, Domínguez Gutiérrez A, Gómez Dos Santos V, Álvarez Díaz N, Tagalos Muñoz A, López Curtis D, Mínguez Ojeda C, de la Parra Sánchez I, Crespo L, Coloma Del Peso A, Burgos Revilla FJ. PMID: 42086443 [PubMed - as supplied by publisher]
	Genetic evidence against a causal relationship between myocardial infarction and urological malignancies. Can J Urol Zhang W, Peng X. PMID: 42086356 [PubMed - indexed for MEDLINE]
	Virtual basket mode in HoLEP: reduced early dysuria and faster continence recovery without loss of efficacy. Can J Urol Özcan S, Dama M, Yorulmaz EM, Köse O, Görgel SN, Ak. PMID: 42086355 [PubMed - indexed for MEDLINE]
	Analysis of risk factors for MRI-invisible prostate cancer-the significance of AGGF1 immunohistochemical detection and PSAD. Can J Urol Lyu J, Yue R, Tian Y, Yang B. PMID: 42086354 [PubMed - indexed for MEDLINE]
	Bladder cancer patients hospitalized in a medicine ward including three fuo cases following bacillus calmette-guÃ©rin immunotherapy. Can J Urol Liatsos G, Zioutou K, Avramidis K, Vamvakaris K, Potamiti-Komi M, Vassilopoulos D. PMID: 42086353 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 187611

Page 1 of 9381



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy